| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |